SUMATRIPTAN AND NAPROXEN SODIUM

SUMATRIPTAN AND NAPROXEN SODIUM was reported 22 times

These side effects are most commonly reported by patients taking SUMATRIPTAN AND NAPROXEN SODIUM:

# Side effect Count
0 SEROTONIN SYNDROME 5
1 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4
2 DRUG INEFFECTIVE 3
3 APPENDICITIS 2
4 DRUG INTERACTION 2
5 INJECTION SITE PAIN 2
6 OFF LABEL USE 2
7 ABDOMINAL PAIN 1
8 ACCIDENTAL EXPOSURE TO PRODUCT 1
9 BLOOD GLUCOSE INCREASED 1
10 CHEMICAL BURN 1
11 CHEST DISCOMFORT 1
12 COLITIS ULCERATIVE 1
13 CONFUSIONAL STATE 1
14 CONVULSION 1
15 DEVICE ISSUE 1
16 DEVICE MALFUNCTION 1
17 DIABETIC KETOACIDOSIS 1
18 DISABILITY 1
19 DIZZINESS 1
20 DRY MOUTH 1
21 DYSPNOEA 1
22 EMBOLIC CEREBRAL INFARCTION 1
23 EMOTIONAL DISTRESS 1
24 EYE IRRITATION 1
25 EYE PAIN 1
26 FALL 1
27 GAIT DISTURBANCE 1
28 GASTRITIS 1
29 HEADACHE 1
30 HOSPITALISATION 1
31 HOT FLUSH 1
32 HYPERGLYCAEMIA 1
33 HYPOAESTHESIA 1
34 INCORRECT DOSE ADMINISTERED 1
35 INJECTION SITE DRYNESS 1
36 INJECTION SITE ERYTHEMA 1
37 INJECTION SITE RASH 1
38 INJECTION SITE REACTION 1
39 MACULAR DEGENERATION 1
40 MACULOPATHY 1
41 MEDICATION OVERUSE HEADACHE 1
42 MIGRAINE 1
43 MUSCULAR WEAKNESS 1
44 NEPHROLITHIASIS 1
45 OPTIC ATROPHY 1
46 OVERDOSE 1
47 PAIN 1
48 PAIN IN JAW 1
49 PARAESTHESIA 1
50 PHOTOPSIA 1
51 PRODUCT DISPENSING ISSUE 1
52 PRODUCT MEASURED POTENCY ISSUE 1
53 PRODUCT SUBSTITUTION ISSUE 1
54 PRODUCT USE IN UNAPPROVED INDICATION 1
55 PSORIASIS 1
56 RASH 1
57 REBOUND EFFECT 1
58 RETINAL DYSTROPHY 1
59 RETINAL PIGMENTATION 1
60 SKIN BURNING SENSATION 1
61 SOMNOLENCE 1
62 TRANSIENT ISCHAEMIC ATTACK 1
63 VERTIGO 1
64 VISUAL IMPAIRMENT 1
65 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1